Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration | Zendy

Darren M. Roberts | Zendy; Germain J. P. Fernando | Zendy; Richard Singer | Zendy; Karina Kennedy | Zendy; Mark L. Lawrence | Zendy; Girish Talaulikar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration

Author(s) -

Darren M. Roberts,

Germain J. P. Fernando,

Richard Singer,

Karina Kennedy,

Mark L. Lawrence,

Girish Talaulikar

Publication year - 2011

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfr005

Subject(s) - antibiotics , cefepime , bioassay , medicine , ampicillin , peritoneal dialysis , microbiology and biotechnology , pharmacology , antibiotic resistance , surgery , biology , imipenem , genetics

Peritoneal dialysis (PD)-associated peritonitis is treated by administration of antibiotics mixed with the PD solution. Data on antibiotic stability for solutions in current use are limited. The aim of this study was to determine the stability of cefepime, cephazolin and ampicillin in three commercial PD solutions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research